Recurrent Pregnancy Loss
4th Edition
Published on 14. November 2024
Book
Paperback/Softback
568 pages
978-93-6616-946-0 (ISBN)
Description
Despite guidelines published by the European Society for Human Reproduction, the American Society of Reproductive Medicine, the Royal College of Obstetricians and Gynaecologists, and many other national bodies, the field of recurrent pregnancy loss (RPL) remains full of controversy. From its definition, two versus three miscarriages, consecutive versus non-consecutive, there is little consensus between guidelines.
RPL is a multi-specialty field encompassing obstetricians, gynaecologists, specialists in ART (assisted reproductive technology), endoscopists, endocrinologists, and rheumatologists. Research in the field is limited by the fact that the number of patients affected by RPL is small, and when further divided by different aetiological factors, each centre deals with a small number of patients.
This book is a comprehensive guide to RPL for obstetricians, gynaecologists, ART specialists, and trainees.
The fourth edition has been thoroughly revised to provide clinicians with the latest advances in the field. Extensive new research has led to the addition of 13 new chapters which include diagnostic recommendations from the various national societies and colleges.
Access to three complimentary videos is included with this invaluable resource.
The previous edition (9789352700912) published in 2018.
RPL is a multi-specialty field encompassing obstetricians, gynaecologists, specialists in ART (assisted reproductive technology), endoscopists, endocrinologists, and rheumatologists. Research in the field is limited by the fact that the number of patients affected by RPL is small, and when further divided by different aetiological factors, each centre deals with a small number of patients.
This book is a comprehensive guide to RPL for obstetricians, gynaecologists, ART specialists, and trainees.
The fourth edition has been thoroughly revised to provide clinicians with the latest advances in the field. Extensive new research has led to the addition of 13 new chapters which include diagnostic recommendations from the various national societies and colleges.
Access to three complimentary videos is included with this invaluable resource.
The previous edition (9789352700912) published in 2018.
More details
Edition
4th Revised edition
Language
English
Place of publication
New Delhi
India
Target group
Professional and scholarly
Edition type
Revised edition
Dimensions
Height: 267 mm
Width: 210 mm
Thickness: 220 mm
Weight
1300 gr
ISBN-13
978-93-6616-946-0 (9789366169460)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Mala Arora FRCOG (UK) FICOG DA (UK) D Obst (Ireland)
Director, Noble IVF Centre, Faridabad, Haryana; Senior Consultant, Fortis La Femme, New Delhi, India; Founder Director, Indian Recurrent Pregnancy Loss Foundation (IRPLF); Vice Chairperson, International Society of Recurrent Pregnancy Loss (ISRPL); Editor-in-Chief, International Journal of Recurrent Pregnancy Loss (IJRPL); Past Chairperson, Indian College of Obstetricians and Gynaecologists (ICOG); Past Vice President, Federation of Obstetric and Gynaecological Societies of India (FOGSI)
Asher Bashiri MD
Full Professor, Director, Recurrent Pregnancy Loss (RPL), Prevention Clinic and Maternity C Ward, Soroka University Medical Centre; Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer -Sheva, Israel; President, World Congress Recurrent Pregnancy Loss (WCRPL); President, International Society Recurrent Pregnancy Loss (ISRPL)
Neelanjana Mukhopadhaya MBBS DGO MMed FICOG FRCOG
Consultant in Gynaecology, Department of Obstetrics and Gynaecology, Bedfordshire Hospitals, UK; Honorary Senior Lecturer, University College Hospital, London; Member, EBCOG Standing Committee on Examinations; Past Chair, Part 1 MRCOG at the Royal College of Obstetricians and Gynaecologists
BS Susheela Rani MBBS MD (Obs & Gynae) PGDMLE (Medical Law & Ethics) FICOG
Director and Consultant, Manjushree Speciality Hospital; Consultant, Sparsh Hospital; President of Bangalore Society of Obstetrics and Gynaecology 2008-2009; Chairperson, BSOG PG Forum from 2000-2021; Secretary, IMS, Bangalore Chapter
Director, Noble IVF Centre, Faridabad, Haryana; Senior Consultant, Fortis La Femme, New Delhi, India; Founder Director, Indian Recurrent Pregnancy Loss Foundation (IRPLF); Vice Chairperson, International Society of Recurrent Pregnancy Loss (ISRPL); Editor-in-Chief, International Journal of Recurrent Pregnancy Loss (IJRPL); Past Chairperson, Indian College of Obstetricians and Gynaecologists (ICOG); Past Vice President, Federation of Obstetric and Gynaecological Societies of India (FOGSI)
Asher Bashiri MD
Full Professor, Director, Recurrent Pregnancy Loss (RPL), Prevention Clinic and Maternity C Ward, Soroka University Medical Centre; Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer -Sheva, Israel; President, World Congress Recurrent Pregnancy Loss (WCRPL); President, International Society Recurrent Pregnancy Loss (ISRPL)
Neelanjana Mukhopadhaya MBBS DGO MMed FICOG FRCOG
Consultant in Gynaecology, Department of Obstetrics and Gynaecology, Bedfordshire Hospitals, UK; Honorary Senior Lecturer, University College Hospital, London; Member, EBCOG Standing Committee on Examinations; Past Chair, Part 1 MRCOG at the Royal College of Obstetricians and Gynaecologists
BS Susheela Rani MBBS MD (Obs & Gynae) PGDMLE (Medical Law & Ethics) FICOG
Director and Consultant, Manjushree Speciality Hospital; Consultant, Sparsh Hospital; President of Bangalore Society of Obstetrics and Gynaecology 2008-2009; Chairperson, BSOG PG Forum from 2000-2021; Secretary, IMS, Bangalore Chapter
Content
1. History, Overview, and Terminology
2. Genetic Evaluation of Products of Conception
3. Monogenic Factors
4. Parental Genetic Testing
5. Epigenetic Factors
6. Cell-free Fetal DNA Testing
7. Male Factors
8. Y Chromosome Microdeletions
9. Male Microbiome, Genetic, and Epigenetic Factors
10. Preimplantation Genetic Screening
11. Hysteroembryoscopy
12. Chronic Endometritis
13. Latent Tuberculosis
14. Cytokines: Success or Failure of Pregnancy
15. Uterine Natural Killer Cells
16. Endometrial Microbiome
17. Endometriosis
18. Adenomyosis
19. Congenital Uterine Malformations
20. Intrauterine Pathologies
21. Arteriovenous Malformations
22. Cervical Insufficiency
23. Role of Laparoscopy
24. Interpregnancy Imaging
25. Ultrasound Evaluation of Endometrium
26. Antiphospholipid Syndrome
27. Autoimmune Diseases
28. Inherited Thrombophilia
29. Thromboelastography
30. Thyroid Disorders
31. Polycystic Ovarian Syndrome
32. Insulin Resistance and Metabolic Syndrome
33. Diminished Ovarian Reserve
34. Hyperhomocysteinemia
35. Role of Vitamin D
36. Obesity
37. Environmental Factors
38. Recurrent Biochemical Pregnancy
39. Recurrent Molar Pregnancies
40. Recurrent Ectopic Pregnancy
41. Role of Natural Micronized Progesterone
42. Role of Dydrogesterone
43. Assisted Reproductive Technology
44. Intravenous Immunoglobulins
45. Evidence for Intravenous Immunoglobulin Use in Recurrent Pregnancy Loss
46. Lipid Emulsion Therapy
47. Role of Human Chorionic Gonadotropin
48. Role of Granulocyte Colony-stimulating Factor
49. Role of Lymphocyte Immunotherapy
50. Role of Micronutrients and Antioxidants
51. Role of Stem Cells for Ovarian Rejuvenation
52. Role of Stem Cells for Endometrial Rejuvenation
53. Tender Loving Care and Reassurance Scans
54. Hysteroscopic Evacuation of the Uterus
55. Placental Pathology
56. Grief Counseling
57. Medicolegal Implications
58. Resurgence of Statins in Recurrent Pregnancy Loss
59. Role of Surrogacy
60. Role of Artificial Intelligence
2. Genetic Evaluation of Products of Conception
3. Monogenic Factors
4. Parental Genetic Testing
5. Epigenetic Factors
6. Cell-free Fetal DNA Testing
7. Male Factors
8. Y Chromosome Microdeletions
9. Male Microbiome, Genetic, and Epigenetic Factors
10. Preimplantation Genetic Screening
11. Hysteroembryoscopy
12. Chronic Endometritis
13. Latent Tuberculosis
14. Cytokines: Success or Failure of Pregnancy
15. Uterine Natural Killer Cells
16. Endometrial Microbiome
17. Endometriosis
18. Adenomyosis
19. Congenital Uterine Malformations
20. Intrauterine Pathologies
21. Arteriovenous Malformations
22. Cervical Insufficiency
23. Role of Laparoscopy
24. Interpregnancy Imaging
25. Ultrasound Evaluation of Endometrium
26. Antiphospholipid Syndrome
27. Autoimmune Diseases
28. Inherited Thrombophilia
29. Thromboelastography
30. Thyroid Disorders
31. Polycystic Ovarian Syndrome
32. Insulin Resistance and Metabolic Syndrome
33. Diminished Ovarian Reserve
34. Hyperhomocysteinemia
35. Role of Vitamin D
36. Obesity
37. Environmental Factors
38. Recurrent Biochemical Pregnancy
39. Recurrent Molar Pregnancies
40. Recurrent Ectopic Pregnancy
41. Role of Natural Micronized Progesterone
42. Role of Dydrogesterone
43. Assisted Reproductive Technology
44. Intravenous Immunoglobulins
45. Evidence for Intravenous Immunoglobulin Use in Recurrent Pregnancy Loss
46. Lipid Emulsion Therapy
47. Role of Human Chorionic Gonadotropin
48. Role of Granulocyte Colony-stimulating Factor
49. Role of Lymphocyte Immunotherapy
50. Role of Micronutrients and Antioxidants
51. Role of Stem Cells for Ovarian Rejuvenation
52. Role of Stem Cells for Endometrial Rejuvenation
53. Tender Loving Care and Reassurance Scans
54. Hysteroscopic Evacuation of the Uterus
55. Placental Pathology
56. Grief Counseling
57. Medicolegal Implications
58. Resurgence of Statins in Recurrent Pregnancy Loss
59. Role of Surrogacy
60. Role of Artificial Intelligence